Tissue specific HPV expression and downregulation of local immune responses in condylomas from HIV seropositive individuals

Sexually Transmitted Infections

Volumn 74, Issue 5, 1998, Pages 349-353

  Arany, Istvan ^a   Evans, Tanya ^a   Tyring, Stephen K ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Condylomas; HIV; Human papillomavirus; Immunity

Indexed keywords

CD1 ANTIGEN; CD16 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GENE PRODUCT; HLA B7 ANTIGEN; HLA DR ANTIGEN; MESSENGER RNA; TRANSACTIVATOR PROTEIN;

ARTICLE; CLINICAL ARTICLE; CONDYLOMA; GENE EXPRESSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; IMMUNOSURVEILLANCE; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; VIRUS GENE; VIRUS TRANSCRIPTION; WART VIRUS;

EID: 0031720308     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.74.5.349     Document Type: Article

References (51)

1. Zur Hausen H. Papillomavirus infections - a major cause of human cancers. Biochim Biophys Acta 1996;1288;F55-78.
2. Schneider A. Pathogenesis of genital HPV infection. Genitourin Med 1993;69;165-73.
3. Viac J, Chardonnet Y, Euvrard S, et al. Langerhans cells, inflammation markers and human papillomavirus infections in benign and malignant epithelial tumors from transplant recipients. J Dermatol 1992;19;67-77.
4. Viac J, Soler C, Chardonnet Y, et al. Expression of immune associated surface antigens of keratinocytes in human papillomavirus-derived lesions. Immunobiol 1993;188;392-402.
5. Connor ME, Stern PL. Loss of MHC class-I expression in cervical carcinomas. Int J Cancer 1990;46;1029-34.
6. Altmann A, Jochmus I, Rosl F. Intra- and extracellular control mechanisms of human papillomavirus infection. Intervirology 1994;37;180-8.
7. Arany I, Rady P, Tyring SK. Alterations in cytokine/anti-oncogene expression in skin lesions caused by "low risk" types of human papillomaviruses. Viral Immunol 1993;6; 255-65.
8. Woodworth CD, Simpson S. Comparative lymphokine secretion by cultured normal human cervical keratinocytes, papillomavirus-immortalized, and carcinoma cell lines. Am J Pathol 1993;142;1544-55.
9. Arany I, Tyring SK. Status of local cellular immunity in interferon responsive and nonresponsive human papillomavirus-associated lesions. Sex Transm Dis 1996;26; 475-80.
10. Arany I, Brysk MM, Brysk H, Tyring SK. Response to interferon treatment decreases with epidermal dedifferentiation in condylomas. Antivir Res 1996;32;19-26.
11. Braun L. Role of human immunodeficiency virus infection in the pathogenesis of human papillomavirus-associated cervical neoplasia. Am J Pathol 1994;144;209-14.
12. Matorras R, Aricte JM, Rementaria A, et al. Human immunodeficiency virus-induced immunosuppression: a risk factor for human papillomavirus infection. Am J Obstet Gynecol 1991;164;42-4.
13. Chirgwin KD, Feldman J, Augenbraun M, et al. Incidence of venereal warts in human immunodeficiency virus-infected and uninfected women. J Infect Dis 1995;172;235-8.
14. Schafer A, Friedmann W, Mielke M, et al. The increased frequency of cervical dysplasia-neoplasia in women infected with the human immunodeficiency virus is related to the degree of immunosuppression. Am J Obstet Gynecol 1991;164;593-9.
15. Johnson JC, Burnett AF, Willet GD, et al. High frequency of latent and clinical human papillomavirus cervical infection in immunocompromised human immunodeficiency virus-infected women. Obstet Gynecol 1992;79;321-7.
16. Feingold AR, Vermund SH, Burk RD, et al. Cervical cytologic abnormalities and papillomavirus in women infected with human immunodeficiency virus. J Acquir Defic Syndr 1990;3;896-903.
17. Vermund SH, Kelley KF, Klein RS, et al. High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. Am J Obstet Gynecol 1991;165;392-400.
18. Resnick RM, Cornelissen MTE, Wright DK, et al. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst 1990;82;1477-1484.
19. Rady P, Arany I, Hughes TK, et al. Type-specific primer-mediated direct sequencing of consensus primer-generated PCR amplicons of human papilloma viruses: a new approach for the simultaneous detection of multiple viral type infections. J Virol Methods 1995;53;245-54.
20. Arany I, Tyring SK. Activation of local cell-mediated immunity in interferon responsive patients with human papillomavirus-associated lesions. J Interferon Cytokine Res 1996;16;453-60.
21. Beckmann AM, Sherman KJ, Myerson D, et al. Comparative virologic studies of condylomata acuminata reveal a lack of dual infections with human papillomaviruses. J Infect Dis 1991;163;393-6.
22. Brown DR, Fife KH. Human papillomavirus infections of the genital tract. Med Clin N Am 1990;74;1455-85.
23. Brown DR, Bryan JT, Cramer H, et al. Detection of multiple human papillomavirus types in condylomata acuminata from immunosuppressed patients. J Infect Dis 1994;170; 759-65.
24. Caussy D, Goedert JJ, Palefsky J, et al. Interaction of human immunodeficiency and papilloma viruses: association with anal epithelial abnormality in homosexual men. Int J Cancer 1990;46;214-19.
25. Melbye M, Palefsky J, Gonzales J, et al. Immune status as a determinant of human papillomavirus detection and its association with anal epithelial abnormalities. Int J Cancer 1990;46;203-6.
26. Arany I, Tyring SK. Systemic immunosuppression by HIV infection influences HPV transcription and thus local immune responses in condylomas. Int J AIDS STD 1998;9:268-71.
27. Fuchs E. Epidermal differentiation: the bare essentials. J Cell Biol 1990;111;2807-14.
28. Barker JNWN, Goodlad JR, Ross EL, et al. Increased epidermal cell proliferation in normal human skin in vivo following local administration of interferon-γ. Am J Pathol 1993;142;1091-7.
29. Roberts JM. Turning DNA replication on and off. Curr Opin Cell Biol 1993;5;201-6.
30. Waga S, Hannon GJ, Beach D, et al. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 1994;369;574-8.
31. Leader M, Collins M, Patel J, et al. Vimentin: an evaluation of its role as a tumour marker. Histopathology 1987;11;63-72.
32. Coleman N, Birley HDL, Renton AM, et al. Immunological events in regressing genital warts. Am J Clin Pathol 1994;102;768-74.
33. McFadden G, Kane K. How DNA viruses perturb functional MHC expression to alter immune recognition. Adv Cancer Res 1994;63;117-209.
34. Lehtinen M, Rantala I, Toivonen A, et al. Depletion of Langerhans cells in cervical HPV infection is associated with replication of the virus. APMIS 1993;101;833-7.
35. Munger K, Phelps WC. The human papillomavirus E7 protein as a transforming and transactivating factor. Biochim Biophys Acta 1993;1155;111-23.
36. Iftner T, Oft M, Bohm S, et al. Transcription of the E6 and E7 genes of human papillomavirus type 6 in anogenital condylomata is restricted to undifferentiated cell layers of the epithelium. J Virol 1992;66;4639-46.
37. Stoler MH, Wolinsky SM, Whitbeck A, et al. Differentiation-linked human papillomavirus types 6 and 11 transcription in genital condylomata revealed by in situ hybridization with message-specific RNA probes. Virology 1989;172;331-40.
38. Fenger C. Histology of the anal canal. Am J Surg Pathol 1988;12;41-55.
39. Williams GR, Talbot IC, Northover JM, et al. Keratin expression in the normal anal canal. Histopathology 1995;26;39-44.
40. Moll R, Franke WW, Schiller DL, et al. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31;11-24.
41. Kim KH, Schwartz F, Fuchs E. Differences in keratin synthesis between normal epithelial cells and squamous cell carcinomas are mediated by vitamin A. Proc Natl Acad Sci USA 1984;81;4280-4.
42. Memar O, Arany I, Tyring SK. Skin associated lymphoid tissue in HIV-1, HPV and HSV infections. J Invest Dermarol 1995;105;99S-104S.
43. Muller H, Weier S, Kojouharoff G, et al. Distribution and infection of Langerhans cells in the skin of HIV-infected healthy subjects and AIDS patients. Res Virol 1993;144;59-67.
44. Hussain LA, Lehner T. Comparative investigation of Langerhans' cells and potential receptors for HIV in oral, genitourinary and rectal epithelia. Immunology 1995;85; 475-84.
45. Cruz PD, Bergstresser PR. Antigen processing and presentation by epidermal Langerhans cells. Induction of immunity or unresponsiveness. Dermatol Clin 1991;9;633-47.
46. Hughes RG, Norval M, Howie SEM. Expression of major histocompatibility class II antigens by Langerhans' cells in cervical intraepithelial neoplasia. J Clin Pathol 1988;41; 253-9.
47. Blauvelt A, Katz SI. The skin as target, vector, and effector organ in human immunodeficiency virus disease. J Invest Dermatol 1995;105;122S-6S.
48. Chang H-K, Gallo RC, Ensoli B Regulation of cellular gene expression and function by the human immunodeficiency virus type 1 tat protein. J Biomed Sci 1995;2;189-202.
49. Tornesello ML, Buonaguro FM, Beth-Giraldo E, et al. Human immunodeficiency virus type 1 tat gene enhances human papillomavirus early gene expression. Intervirology 1993;36;57-64.
50. Vernon SD, Hart CE, Reeves WC, et al. The HIV-1 tat protein enhances E2-dependent human papillomavirus 16 transcription. Virus Res 1993;27;133-45.
51. Breese PL, Judson FN, Penley KA, et al. Anal human papillomavirus infection among homosexual and bisexual men: prevalence of type-specific infection and association with human immunodeficiency virus. Sex Transm Dis 1995;22; 7-14.